2-arachidonoylglycerol (Czech Wikipedia)

Analysis of information sources in references of the Wikipedia article "2-arachidonoylglycerol" in Czech language version.

refsWebsite
Global rank Czech rank
2nd place
4th place
4th place
8th place
1st place
1st place
610th place
203rd place
4,455th place
3,667th place
low place
low place
low place
low place
low place
low place
low place
low place

cannabis-med.org

doi.org

dx.doi.org

  • Stella N, Schweitzer P, Piomelli D. A second endogenous cannabinoid that modulates long-term potentiation. Nature. August 1997, s. 773–8. DOI 10.1038/42015. PMID 9285589. 
  • Sugiura T, Kodaka T, Nakane S. Evidence that the cannabinoid CB1 receptor is a 2-arachidonoylglycerol receptor. Structure-activity relationship of 2-arachidonoylglycerol, ether-linked analogues, and related compounds. The Journal of Biological Chemistry. January 1999, s. 2794–801. Dostupné v archivu pořízeném dne 2019-09-12. DOI 10.1074/jbc.274.5.2794. PMID 9915812.  Archivovaná kopie. www.jbc.org [online]. [cit. 2019-02-25]. Dostupné v archivu pořízeném z originálu. 
  • Kondo S, Kondo H, Nakane S. 2-Arachidonoylglycerol, an endogenous cannabinoid receptor agonist: identification as one of the major species of monoacylglycerols in various rat tissues, and evidence for its generation through Ca2+-dependent and -independent mechanisms. FEBS Letters. June 1998, s. 152–6. Dostupné online. DOI 10.1016/S0014-5793(98)00581-X. PMID 9650580. 
  • Fride E, Bregman T, Kirkham TC. Endocannabinoids and food intake: newborn suckling and appetite regulation in adulthood. Experimental Biology and Medicine. April 2005, s. 225–234. Dostupné online. DOI 10.1177/153537020523000401. PMID 15792943. 
  • Sugiura T, Kondo S, Sukagawa A. 2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain. Biochem. Biophys. Res. Commun.. October 1995, s. 89–97. Dostupné online [cit. 2009-01-27]. DOI 10.1006/bbrc.1995.2437. PMID 7575630. 
  • Mechoulam R, Ben-Shabat S, Hanuš L. Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. Biochemical pharmacology. June 1995, s. 83–90. Dostupné online. DOI 10.1016/0006-2952(95)00109-D. PMID 7605349. 
  • Savinainen JR, Järvinen T, Laine K, Laitinen JT. Despite substantial degradation, 2-arachidonoylglycerol is a potent full efficacy agonist mediating CB(1) receptor-dependent G-protein activation in rat cerebellar membranes. British Journal of Pharmacology. October 2001, s. 664–72. DOI 10.1038/sj.bjp.0704297. PMID 11588122. 
  • Blankman JL, Simon GM, Cravatt BF. A comprehensive profile of brain enzymes that hydrolyze the endocannabinoid 2-arachidonoylglycerol. Chemistry & Biology. December 2007, s. 1347–56. DOI 10.1016/j.chembiol.2007.11.006. PMID 18096503. 
  • SAVINAINEN, JR; SAARIO, SM; LAITINEN, JT. The serine hydrolases MAGL, ABHD6 and ABHD12 as guardians of 2-arachidonoylglycerol signalling through cannabinoid receptors. Acta Physiologica. 2012, s. 267–76. DOI 10.1111/j.1748-1716.2011.02280.x. PMID 21418147. 
  • KACZOCHA, M.; GLASER, S.T.; DEUTSCH, D.G. Identification of intracellular carriers for the endocannabinoid anandamide. Proceedings of the National Academy of Sciences of the United States of America. 2009, s. 6375–6380. DOI 10.1073/pnas.0901515106. PMID 19307565. 
  • ODDI, S.; FEZZA, F.; PASQUARIELLO, N.; D'AGOSTINO, A.; CATANZARO, G.; DE SIMONE, C.; RAPINO, C. Molecular identification of albumin and Hsp70 as cytosolic anandamide-binding proteins. Chemistry & Biology. 2009, s. 624–632. DOI 10.1016/j.chembiol.2009.05.004. PMID 19481477. 
  • Murataeva N, Straiker A, Mackie K. Parsing the players: 2-arachidonoylglycerol synthesis and degradation in the CNS. Br J Pharmacol. Mar 2014, s. 1379–91. DOI 10.1111/bph.12411. 

ebmonline.org

elsevier.com

linkinghub.elsevier.com

jbc.org

  • Sugiura T, Kodaka T, Nakane S. Evidence that the cannabinoid CB1 receptor is a 2-arachidonoylglycerol receptor. Structure-activity relationship of 2-arachidonoylglycerol, ether-linked analogues, and related compounds. The Journal of Biological Chemistry. January 1999, s. 2794–801. Dostupné v archivu pořízeném dne 2019-09-12. DOI 10.1074/jbc.274.5.2794. PMID 9915812.  Archivovaná kopie. www.jbc.org [online]. [cit. 2019-02-25]. Dostupné v archivu pořízeném z originálu. 

lmreview.com

nel.edu

nih.gov

ncbi.nlm.nih.gov

  • Stella N, Schweitzer P, Piomelli D. A second endogenous cannabinoid that modulates long-term potentiation. Nature. August 1997, s. 773–8. DOI 10.1038/42015. PMID 9285589. 
  • Sugiura T, Kodaka T, Nakane S. Evidence that the cannabinoid CB1 receptor is a 2-arachidonoylglycerol receptor. Structure-activity relationship of 2-arachidonoylglycerol, ether-linked analogues, and related compounds. The Journal of Biological Chemistry. January 1999, s. 2794–801. Dostupné v archivu pořízeném dne 2019-09-12. DOI 10.1074/jbc.274.5.2794. PMID 9915812.  Archivovaná kopie. www.jbc.org [online]. [cit. 2019-02-25]. Dostupné v archivu pořízeném z originálu. 
  • Kondo S, Kondo H, Nakane S. 2-Arachidonoylglycerol, an endogenous cannabinoid receptor agonist: identification as one of the major species of monoacylglycerols in various rat tissues, and evidence for its generation through Ca2+-dependent and -independent mechanisms. FEBS Letters. June 1998, s. 152–6. Dostupné online. DOI 10.1016/S0014-5793(98)00581-X. PMID 9650580. 
  • Fride E, Bregman T, Kirkham TC. Endocannabinoids and food intake: newborn suckling and appetite regulation in adulthood. Experimental Biology and Medicine. April 2005, s. 225–234. Dostupné online. DOI 10.1177/153537020523000401. PMID 15792943. 
  • Sugiura T, Kondo S, Sukagawa A. 2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain. Biochem. Biophys. Res. Commun.. October 1995, s. 89–97. Dostupné online [cit. 2009-01-27]. DOI 10.1006/bbrc.1995.2437. PMID 7575630. 
  • Mechoulam R, Ben-Shabat S, Hanuš L. Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. Biochemical pharmacology. June 1995, s. 83–90. Dostupné online. DOI 10.1016/0006-2952(95)00109-D. PMID 7605349. 
  • Savinainen JR, Järvinen T, Laine K, Laitinen JT. Despite substantial degradation, 2-arachidonoylglycerol is a potent full efficacy agonist mediating CB(1) receptor-dependent G-protein activation in rat cerebellar membranes. British Journal of Pharmacology. October 2001, s. 664–72. DOI 10.1038/sj.bjp.0704297. PMID 11588122. 
  • Blankman JL, Simon GM, Cravatt BF. A comprehensive profile of brain enzymes that hydrolyze the endocannabinoid 2-arachidonoylglycerol. Chemistry & Biology. December 2007, s. 1347–56. DOI 10.1016/j.chembiol.2007.11.006. PMID 18096503. 
  • SAVINAINEN, JR; SAARIO, SM; LAITINEN, JT. The serine hydrolases MAGL, ABHD6 and ABHD12 as guardians of 2-arachidonoylglycerol signalling through cannabinoid receptors. Acta Physiologica. 2012, s. 267–76. DOI 10.1111/j.1748-1716.2011.02280.x. PMID 21418147. 
  • KACZOCHA, M.; GLASER, S.T.; DEUTSCH, D.G. Identification of intracellular carriers for the endocannabinoid anandamide. Proceedings of the National Academy of Sciences of the United States of America. 2009, s. 6375–6380. DOI 10.1073/pnas.0901515106. PMID 19307565. 
  • ODDI, S.; FEZZA, F.; PASQUARIELLO, N.; D'AGOSTINO, A.; CATANZARO, G.; DE SIMONE, C.; RAPINO, C. Molecular identification of albumin and Hsp70 as cytosolic anandamide-binding proteins. Chemistry & Biology. 2009, s. 624–632. DOI 10.1016/j.chembiol.2009.05.004. PMID 19481477. 

web.archive.org